Lyten 3D-Graphene Cement Patent (WO/2025)

Product · Materials Science

Product · InnDex 28 · Evidence provided · High specification risk

Mesoporous 3D-graphene cement additive enabling high-SCM concrete with accelerated strength gain.

Lyten's patented graphene-based admixture (0.05–2 wt%) targets the AEC challenge of scaling supplementary cementitious materials (SCM) in concrete while maintaining early strength and durability. It functions as a nucleation template and pozzolanic reaction accelerator, theoretically enabling 70% SCM incorporation while meeting ASTM C1157 standards. Commercial deployment claimed Q2 2026 with active trials at four major concrete producers.

Lyten's patented graphene admixture — dosed at 0.05–2 wt% — acts as a nucleation template and pozzolanic accelerator in cement paste, theoretically enabling up to 70% SCM incorporation while meeting ASTM C1157 benchmarks, with commercial deployment claimed for Q2 2026 across four major concrete producer trials. The dosage efficiency claim is significant if verified: enabling very high SCM loadings without strength compromise would be a material advance in low-carbon concrete, particularly as regulatory pressure on embodied carbon intensifies. The record carries one piece of evidence, but it is Lyten's own research with unnamed trial partners and no independent validation — no peer-reviewed study, no third-party LCA, and no published EPD. The embodied carbon claim is explicitly unquantified: graphene production is energy-intensive, and the net carbon benefit depends entirely on production method and graphene source, a number that has not been disclosed. Long-term durability of graphene-modified cement paste over twenty-plus years — dispersion stability, aggregate interfacial bonding, and carbonation resistance — is structurally unknowable at this stage. A specifier should treat this as a high-potential admixture technology in early commercial claiming phase, appropriate for a monitored trial on a project with a concrete innovation mandate, but far short of the evidence threshold for standard specification.

Strengths

Considerations

Risks

Performance

Reality check

Patent (WO/2025) is real and publicly filed. Commercial trials with named partners are claimed but no independent verification, test reports, or third-party lab data available. Website source is obfuscated JavaScript (Divi popup framework) with no substantive technical content or trial results. No published LCA, EPD, or CO₂ quantification. Q2 2026 launch date is forward-looking; pre-commercial status. Mechanism (graphene nucleation + pozzolanic acceleration) is chemically plausible but unvalidated in published literature specific to this formulation. Lyten's credibility in graphene materials is real (other applications) but does not transfer to cement without field evidence.

#concrete_admixture #carbon_reduction #scm_enabler #pozzolanic_acceleration #graphene

Source